Real-World Evidence for Decisions in Diabetes

Publications

2026

  • A cohort description and comparison of four European national diabetes registries for the REDDIE project
    Jonah J C Thomas, Stefanie Lanzinger, Kathrine Kold Soerensen, Henrik Imberg, Stefanie Schmid, Emma Barron, Reinhard Holl, Ulrik Pedersen‐Bjergaard, Amanda Adler, Martina Vettoretti, Shivani Misra, Jonathan Valabhji, Kamlesh Khunti, Marcus Lind, Christian Torp‐Pedersen, Julia K Mader, Pratik Choudhary; the REDDIE study group
    doi: 10.1111/dme.70112
  • Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trial
    Puriya Daniel Würtz Yazdanfard, Kathrine Kold Sørensen, Bochra Zareini, Ulrik Pedersen-Bjergaard, Johan Sebastian Ohlendorff, Anders Munch, Mikkel Porsborg Andersen, Rasmus Bo Hasselbalch, Henrik Imberg, Viktor Tasseleus, Marcus Lind, Jonathan Valabhji, Pratik Choudhary, Kamlesh Khunti, Stefanie Schmid, Stefanie Lanzinger, Julia Mader, Thomas Alexander Gerds, Christian Torp-Pedersen & The REDDIE consortium

2025

  • Evaluating propensity score-based methods in treatment effect estimation: a simulation study
    Sara Poletto, Enrico Longato, Erica Tavazzi, Martina Vettoretti
  • A Dynamic Bayesian Network Approach for Generating Synthetic Longitudinal Clinical Data
    Sara Poletto, Noemi Gonzato, Erica Tavazzi, Enrico Longato, Amanda Adler, Mari-Anne Gall, Matthias Müllenborn, Barbara Di Camillo, Martina Vettoretti
    doi: 10.1109/BIBM66473.2025.11356456
  • Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes
    Kathrine Kold Sørensen, Puriya Daniel Würtz Yazdanfard, Bochra Zareini, Ulrik Pedersen-Bjergaard, Vanja Kosjerina, Mikkel Porsborg Andersen, Anders Munch, Johan Sebastian Ohlendorff, Stefanie Schmid, Stefanie Lanzinger, Pratik Choudhary, Clare Gillies, Safoora Gharibzadeh, Marcus Lind, Viktor Tasselius, Jens Michelsen, Thomas Alexander Gerds & Christian Torp-Pedersen
    doi: https://doi.org/10.1186/s12933-025-02915-1
  • Sustained Glucagon-Like Peptide-1 Receptor Agonist Treatment Improves Glycemic Control and Reduces All-Cause Mortality Compared to Dipeptidyl Peptidase-4 Inhibitors: A Real-World Target Trial Emulation in Type 2 Diabetes
    Kathrine Kold Sørensen; Puriya Daniel Würtz Yazdanfard; Bochra Zareini; Hannah Karin Wood-Kurland; Ulrik Pedersen-Bjergaard; Mikkel Porsborg Andersen; Jens Michelsen; Henrik Imberg; Marcus Lind; Sara Hallström; Stefanie Lanzinger; Anders Munch; Johan Sebastian Ohlendorff; Thomas Alexander Gerds; Christian Torp-Pedersen & The REDDIE consortium

2024

RWD Dashboard
Project partners